Prof. Andrew Shaw
CEO & Founder
PhD Physical Chemistry, MA Natural Sciences. Academic entrepreneur with a successful tech exit, and 83 Publications. Head of Research Group, University of Exeter and Postdoctoral Research at Stanford.
Andrew Vincent
Chief Marketing Officer
35+ years of healthcare & life sciences marketing, communications & commercialisation experience spanning UK, EU, US and Caribbean, with two successful exits, one medtech distribution, one healthcare provider.
Sakura Holloway
NED, BIF Opportunities LP
Sakura represents Future Planet Capital as Portfolio Manager for their BIF Opportunities Fund, a specialist Life Sciences and AgTech venture capital fund investing in UK university spinouts at Series A/B stage.
Yves Le Goff
Strategic Adviser and CCO, EU Markets
Yves co-led Attomarker’s GBP1.5m Future Fund 2020 funding round. He is a former investment banker (Goldman Sachs, Credit Suisse) and early-stage investor
Dr Shivali Kohli
Director of Products
With a PhD in neuropharmacology and 10+ years in scientific research at leading universities, she brings a wealth of experience in project and team management.
Dr Philip James-Pemberton
Director of Research
Philip James-Pemberton leads the development of innovative diagnostic technologies. With a background in biomedical research and extensive experience in nanophotonic testing, he specialises in translating cutting-edge science into practical healthcare solutions. Philip plays a key role in advancing rapid, precise diagnostics for real-world applications.
Chandru R. Chandrasekar
Director of International Development
Chandru is an investor and former orthopaedic surgeon with deep connections in India and Singapore, with a mission to nurture sustainable technology platforms at ‘India Scale, India Price’.
Steve Brine
Advisor
Former MP, Health Minister and Chair of the cross-party Commons Health Select Committee, Steve is an authoritative voice on public health, healthcare innovation, and the prevention of ill health.